DrugPatentWatch Database Preview

Sandoz Inc Company Profile

SANDOZ INC has one hundred and thirty-eight approved drugs.

There are four US patents protecting SANDOZ INC drugs. There are fifteen tentative approvals on SANDOZ INC drugs.

There are twenty patent family members on SANDOZ INC drugs in eighteen countries and two hundred and eight supplementary protection certificates in thirteen countries.

International Patents:	20
US Patents:	4
Tradenames:	111
Ingredients:	107
NDAs:	138
Patent Litigation for Sandoz Inc:	See patent lawsuits for Sandoz Inc
PTAB Cases with Sandoz Inc as petitioner:	See PTAB cases with Sandoz Inc as petitioner

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sandoz Inc	KETOROLAC TROMETHAMINE	ketorolac tromethamine	SOLUTION/DROPS;OPHTHALMIC	078721-001	Nov 5, 2009	AT	RX	No	No		➤ Sign Up				➤ Sign Up
Sandoz Inc	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET, EXTENDED RELEASE;ORAL	202353-003	Dec 4, 2014	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Sandoz Inc	ZIPRASIDONE HYDROCHLORIDE	ziprasidone hydrochloride	CAPSULE;ORAL	077562-003	Jun 1, 2012	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Sandoz Inc	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OTIC	062423-001	Aug 25, 1983	AT	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sandoz Inc	BETOPTIC	betaxolol hydrochloride	SOLUTION/DROPS;OPHTHALMIC	019270-001	Aug 30, 1985	4,252,984	➤ Sign Up
Sandoz Inc	BETOPTIC	betaxolol hydrochloride	SOLUTION/DROPS;OPHTHALMIC	019270-001	Aug 30, 1985	4,311,708	➤ Sign Up
Sandoz Inc	BETOPTIC	betaxolol hydrochloride	SOLUTION/DROPS;OPHTHALMIC	019270-001	Aug 30, 1985	4,342,783	➤ Sign Up
Sandoz Inc	ANGIOMAX	bivalirudin	INJECTABLE;INTRAVENOUS	020873-001	Dec 15, 2000	5,196,404*PED	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	For Injection	250 mg/vial	➤ Subscribe	2009-09-01

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	9951273	➤ Sign Up
Taiwan	I262797	➤ Sign Up
South Africa	200004413	➤ Sign Up
Brazil	9910113	➤ Sign Up
Country	Patent Number	Estimated Expiration

Subscribe to access the full database, or try a Free Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0321122	SPC/GB96/057	United Kingdom	➤ Sign Up	PRODUCT NAME: TOPOTECAN; REGISTERED: CH IKS-NR:53857 19961016; UK EU/1/96/027/001 19961112; UK EU/1/96/027/002 19961112
1746976	300885	Netherlands	➤ Sign Up	PRODUCT NAME: ONIVYDE - IRINOTECAN; REGISTRATION NO/DATE: EU/1/16/1130 20161018
0961612	SZ 41/2009	Austria	➤ Sign Up	PRODUCT NAME: PACLITAXEL ALBUMIN
0480717	19/1999	Austria	➤ Sign Up	PRODUCT NAME: MONTELUKAST ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, INSBESONDERE MONTELUKASTNATRIUM; NAT. REGISTRATION NO/DATE: 1-22765 UND 1-22766 19981030; FIRST REGISTRATION: FI 12766 UND 12767 19970825
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.